No Data
No Data
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth
Mineralys Therapeutics(MLYS.US) Officer Sells US$1,500 in Common Stock
$Mineralys Therapeutics(MLYS.US)$ Officer Rodman David Malcom sold 100 shares of common stock on May 9, 2024 at an average price of $15 for a total value of $1,500.Source: Announcement What is stateme
Mineralys Therapeutics: Strong Buy on Upcoming ADVANCE Trial Results and Robust Financial Health
Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Anika Therapeutics (ANIK)
Express News | Mineralys Therapeutics Q1 2024 GAAP EPS $(0.70) Misses $(0.67) Estimate